KL001 |
A cryptochrome protein stabilizer; inhibits ubiquitin-induced degradation… |
10 mg |
13878-10 |
More Info
|
KL001 |
A cryptochrome protein stabilizer; inhibits ubiquitin-induced degradation… |
25 mg |
13878-25 |
More Info
|
KL001 |
A cryptochrome protein stabilizer; inhibits ubiquitin-induced degradation… |
5 mg |
13878-5 |
More Info
|
KLH45 |
An inhibitor of DDHD2 (IC50 = 1.3 nM); selective for DDHD2 over greater th… |
1 mg |
19889-1 |
More Info
|
KLH45 |
An inhibitor of DDHD2 (IC50 = 1.3 nM); selective for DDHD2 over greater th… |
10 mg |
19889-10 |
More Info
|
KLH45 |
An inhibitor of DDHD2 (IC50 = 1.3 nM); selective for DDHD2 over greater th… |
25 mg |
19889-25 |
More Info
|
KLH45 |
An inhibitor of DDHD2 (IC50 = 1.3 nM); selective for DDHD2 over greater th… |
5 mg |
19889-5 |
More Info
|
Klotho-derived Peptide 1 (56-87) (human) (trifluoroacetate salt) |
A TGF-β disrupting peptide; binds to ALK5 and TGFBR2 (Kds = 1.41 and… |
1 mg |
38166-1 |
More Info
|
Klotho-derived Peptide 1 (56-87) (human) (trifluoroacetate salt) |
A TGF-β disrupting peptide; binds to ALK5 and TGFBR2 (Kds = 1.41 and… |
10 mg |
38166-10 |
More Info
|
Klotho-derived Peptide 1 (56-87) (human) (trifluoroacetate salt) |
A TGF-β disrupting peptide; binds to ALK5 and TGFBR2 (Kds = 1.41 and… |
5 mg |
38166-5 |
More Info
|
Klotho-derived Peptide 1 (56-87) (human) (trifluoroacetate salt) |
A TGF-β disrupting peptide; binds to ALK5 and TGFBR2 (Kds = 1.41 and… |
500 µg |
38166-500 |
More Info
|
KM 11060 |
A F508del-CFTR corrector; increases cell surface expression and restores c… |
10 mg |
23481-10 |
More Info
|
KM 11060 |
A F508del-CFTR corrector; increases cell surface expression and restores c… |
25 mg |
23481-25 |
More Info
|
KM 11060 |
A F508del-CFTR corrector; increases cell surface expression and restores c… |
5 mg |
23481-5 |
More Info
|
KM 11060 |
A F508del-CFTR corrector; increases cell surface expression and restores c… |
50 mg |
23481-50 |
More Info
|
KM 233 |
Δ8-THC analog with 13-fold selectivity for the CB2 receptor (Kis = 1… |
1 mg |
10640-1 |
More Info
|
KM 233 |
Δ8-THC analog with 13-fold selectivity for the CB2 receptor (Kis = 1… |
10 mg |
10640-10 |
More Info
|
KM 233 |
Δ8-THC analog with 13-fold selectivity for the CB2 receptor (Kis = 1… |
25 mg |
10640-25 |
More Info
|
KM 233 |
Δ8-THC analog with 13-fold selectivity for the CB2 receptor (Kis = 1… |
5 mg |
10640-5 |
More Info
|
KML29 |
An O-hexafluoroisopropyl carbamate analog of JZL 184 that potently and sel… |
10 mg |
11777-10 |
More Info
|
KML29 |
An O-hexafluoroisopropyl carbamate analog of JZL 184 that potently and sel… |
100 mg |
11777-100 |
More Info
|
KML29 |
An O-hexafluoroisopropyl carbamate analog of JZL 184 that potently and sel… |
5 mg |
11777-5 |
More Info
|
KML29 |
An O-hexafluoroisopropyl carbamate analog of JZL 184 that potently and sel… |
50 mg |
11777-50 |
More Info
|
KMN-80 |
A selective, potent agonist of EP4 with an IC50 value of 3 nM (versus 1.4… |
1 mg |
15435-1 |
More Info
|
KMN-80 |
A selective, potent agonist of EP4 with an IC50 value of 3 nM (versus 1.4… |
500 µg |
15435-500 |
More Info
|
KN-62 |
A selective, cell permeable inhibitor of CaMKII (IC50 = 900 nM) |
1 mg |
13318-1 |
More Info
|
KN-62 |
A selective, cell permeable inhibitor of CaMKII (IC50 = 900 nM) |
10 mg |
13318-10 |
More Info
|
KN-62 |
A selective, cell permeable inhibitor of CaMKII (IC50 = 900 nM) |
25 mg |
13318-25 |
More Info
|
KN-62 |
A selective, cell permeable inhibitor of CaMKII (IC50 = 900 nM) |
5 mg |
13318-5 |
More Info
|
KN-93 |
A selective inhibitor of CaMKII, competitively blocking CaM binding to the… |
1 mg |
13319-1 |
More Info
|
KN-93 |
A selective inhibitor of CaMKII, competitively blocking CaM binding to the… |
10 mg |
13319-10 |
More Info
|
KN-93 |
A selective inhibitor of CaMKII, competitively blocking CaM binding to the… |
5 mg |
13319-5 |
More Info
|
KN-92 (hydrochloride) |
An inactive derivative of KN-93, the selective inhibitor of CaMKII; ineffe… |
1 mg |
9000890-1 |
More Info
|
KN-92 (hydrochloride) |
An inactive derivative of KN-93, the selective inhibitor of CaMKII; ineffe… |
10 mg |
9000890-10 |
More Info
|
KN-92 (hydrochloride) |
An inactive derivative of KN-93, the selective inhibitor of CaMKII; ineffe… |
5 mg |
9000890-5 |
More Info
|
KN-93 (hydrochloride) |
A selective inhibitor of CaMKII, competitively blocking CaM binding to the… |
1 mg |
13864-1 |
More Info
|
KN-93 (hydrochloride) |
A selective inhibitor of CaMKII, competitively blocking CaM binding to the… |
10 mg |
13864-10 |
More Info
|
KN-93 (hydrochloride) |
A selective inhibitor of CaMKII, competitively blocking CaM binding to the… |
5 mg |
13864-5 |
More Info
|
KN-93 (phosphate) |
A CaMKII inhibitor (Ki = 370 nM) that inhibits the α- and β-sub… |
1 mg |
21472-1 |
More Info
|
KN-93 (phosphate) |
A CaMKII inhibitor (Ki = 370 nM) that inhibits the α- and β-sub… |
10 mg |
21472-10 |
More Info
|
KN-93 (phosphate) |
A CaMKII inhibitor (Ki = 370 nM) that inhibits the α- and β-sub… |
25 mg |
21472-25 |
More Info
|
KN-93 (phosphate) |
A CaMKII inhibitor (Ki = 370 nM) that inhibits the α- and β-sub… |
5 mg |
21472-5 |
More Info
|
Ko 143 |
A potent and selective inhibitor of BCRP, preventing the export of mitoxan… |
10 mg |
15215-10 |
More Info
|
Ko 143 |
A potent and selective inhibitor of BCRP, preventing the export of mitoxan… |
25 mg |
15215-25 |
More Info
|
Ko 143 |
A potent and selective inhibitor of BCRP, preventing the export of mitoxan… |
5 mg |
15215-5 |
More Info
|
Ko 143 |
A potent and selective inhibitor of BCRP, preventing the export of mitoxan… |
50 mg |
15215-50 |
More Info
|
KO947 |
An ERK inhibitor (IC50 = 50-fold selective for ERK over a panel of 450 kin… |
1 mg |
29213-1 |
More Info
|
KO947 |
An ERK inhibitor (IC50 = 50-fold selective for ERK over a panel of 450 kin… |
10 mg |
29213-10 |
More Info
|
KO947 |
An ERK inhibitor (IC50 = 50-fold selective for ERK over a panel of 450 kin… |
25 mg |
29213-25 |
More Info
|
KO947 |
An ERK inhibitor (IC50 = 50-fold selective for ERK over a panel of 450 kin… |
5 mg |
29213-5 |
More Info
|
Kobe 0065 |
An orally active Ras inhibitor with selectivity for H-Ras (Ki = 46 µ… |
1 mg |
16261-1 |
More Info
|
Kobe 0065 |
An orally active Ras inhibitor with selectivity for H-Ras (Ki = 46 µ… |
10 mg |
16261-10 |
More Info
|
Kobe 0065 |
An orally active Ras inhibitor with selectivity for H-Ras (Ki = 46 µ… |
25 mg |
16261-25 |
More Info
|
Kobe 0065 |
An orally active Ras inhibitor with selectivity for H-Ras (Ki = 46 µ… |
5 mg |
16261-5 |
More Info
|
Kobe 2602 |
A selective Ras inhibitor that blocks H-Ras GTP binding to c-Raf-1 (Ki = 1… |
10 mg |
16262-10 |
More Info
|
Kobe 2602 |
A selective Ras inhibitor that blocks H-Ras GTP binding to c-Raf-1 (Ki = 1… |
100 mg |
16262-100 |
More Info
|
Kobe 2602 |
A selective Ras inhibitor that blocks H-Ras GTP binding to c-Raf-1 (Ki = 1… |
50 mg |
16262-50 |
More Info
|
Kobe 2602 |
A selective Ras inhibitor that blocks H-Ras GTP binding to c-Raf-1 (Ki = 1… |
500 mg |
16262-500 |
More Info
|
Kocurin |
A peptide antibiotic; active against MRSA (MIC = 0.25 µg / ml), as w… |
1 mg |
29125-1 |
More Info
|
KOdiA-PC |
Oxidized LDL (oxLDL) particles contain low molecular weight species which… |
1 mg |
62945-1 |
More Info
|
KOdiA-PC |
Oxidized LDL (oxLDL) particles contain low molecular weight species which… |
10 mg |
62945-10 |
More Info
|
KOdiA-PC |
Oxidized LDL (oxLDL) particles contain low molecular weight species which… |
5 mg |
62945-5 |
More Info
|
KOdiA-PC |
Oxidized LDL (oxLDL) particles contain low molecular weight species which… |
500 µg |
62945-500 |
More Info
|
Kojic Acid |
A tyrosinase inhibitor (IC50 = 30.6 µM); decreases growth of Leishma… |
10 g |
22712-10 |
More Info
|
Kojic Acid |
A tyrosinase inhibitor (IC50 = 30.6 µM); decreases growth of Leishma… |
100 g |
22712-100 |
More Info
|
Kojic Acid |
A tyrosinase inhibitor (IC50 = 30.6 µM); decreases growth of Leishma… |
5 g |
22712-5 |
More Info
|
Kojic Acid |
A tyrosinase inhibitor (IC50 = 30.6 µM); decreases growth of Leishma… |
50 g |
22712-50 |
More Info
|
Kotanin A |
A fungal metabolite; produced by A. glaucus (A. clavatus), A. alliaceus, a… |
2.5 mg |
24917-25 |
More Info
|
Kotanin A |
A fungal metabolite; produced by A. glaucus (A. clavatus), A. alliaceus, a… |
500 µg |
24917-500 |
More Info
|
Koumine |
An alkaloid with diverse biological activities; inhibits the proliferation… |
1 mg |
36210-1 |
More Info
|
Koumine |
An alkaloid with diverse biological activities; inhibits the proliferation… |
10 mg |
36210-10 |
More Info
|
Koumine |
An alkaloid with diverse biological activities; inhibits the proliferation… |
25 mg |
36210-25 |
More Info
|
Koumine |
An alkaloid with diverse biological activities; inhibits the proliferation… |
5 mg |
36210-5 |
More Info
|
KP372-1 |
A specific Akt inhibitor; inhibits Akt, PDK1, and FLT3 in acute myelogenou… |
1 mg |
17808-1 |
More Info
|
KP372-1 |
A specific Akt inhibitor; inhibits Akt, PDK1, and FLT3 in acute myelogenou… |
10 mg |
17808-10 |
More Info
|
KP372-1 |
A specific Akt inhibitor; inhibits Akt, PDK1, and FLT3 in acute myelogenou… |
5 mg |
17808-5 |
More Info
|
K6PC-5 |
An SPHK1 activator; activates SPHK1 in F9-12 cell lysates and isolated mur… |
10 mg |
34070-10 |
More Info
|
K6PC-5 |
An SPHK1 activator; activates SPHK1 in F9-12 cell lysates and isolated mur… |
25 mg |
34070-25 |
More Info
|
K6PC-5 |
An SPHK1 activator; activates SPHK1 in F9-12 cell lysates and isolated mur… |
5 mg |
34070-5 |
More Info
|
KPT-185 |
An inhibitor of XPO1 / CRM1; reduces proliferation in a panel of patient-d… |
10 mg |
26074-10 |
More Info
|
KPT-185 |
An inhibitor of XPO1 / CRM1; reduces proliferation in a panel of patient-d… |
25 mg |
26074-25 |
More Info
|
KPT-185 |
An inhibitor of XPO1 / CRM1; reduces proliferation in a panel of patient-d… |
5 mg |
26074-5 |
More Info
|
KPT-276 |
An inhibitor of XPO1 / CRM1; increases survival and reduces spleen weight… |
10 mg |
29158-10 |
More Info
|
KPT-276 |
An inhibitor of XPO1 / CRM1; increases survival and reduces spleen weight… |
25 mg |
29158-25 |
More Info
|
KPT-276 |
An inhibitor of XPO1 / CRM1; increases survival and reduces spleen weight… |
5 mg |
29158-5 |
More Info
|
KPT-276 |
An inhibitor of XPO1 / CRM1; increases survival and reduces spleen weight… |
50 mg |
29158-50 |
More Info
|
KPT-6566 |
A covalent PIN1 inhibitor ( IC50 = 0.64 µM); inhibits cell prolifera… |
10 mg |
37308-10 |
More Info
|
KPT-6566 |
A covalent PIN1 inhibitor ( IC50 = 0.64 µM); inhibits cell prolifera… |
25 mg |
37308-25 |
More Info
|
KPT-6566 |
A covalent PIN1 inhibitor ( IC50 = 0.64 µM); inhibits cell prolifera… |
5 mg |
37308-5 |
More Info
|
KPT-6566 |
A covalent PIN1 inhibitor ( IC50 = 0.64 µM); inhibits cell prolifera… |
50 mg |
37308-50 |
More Info
|
KR-32568 |
An NHE-1 inhibitor (IC50 = 230 nM); restores cardiac contractile function… |
1 mg |
23968-1 |
More Info
|
KR-32568 |
An NHE-1 inhibitor (IC50 = 230 nM); restores cardiac contractile function… |
5 mg |
23968-5 |
More Info
|
KR-33493 |
An inhibitor of FAF1; inhibits chemical hypoxia-induced apoptosis in H9c2… |
1 mg |
22071-1 |
More Info
|
KR-33493 |
An inhibitor of FAF1; inhibits chemical hypoxia-induced apoptosis in H9c2… |
10 mg |
22071-10 |
More Info
|
KR-33493 |
An inhibitor of FAF1; inhibits chemical hypoxia-induced apoptosis in H9c2… |
25 mg |
22071-25 |
More Info
|
KR-33493 |
An inhibitor of FAF1; inhibits chemical hypoxia-induced apoptosis in H9c2… |
5 mg |
22071-5 |
More Info
|
K-Ras(G12C) Inhibitor 12 |
An allosteric inhibitor of oncogenic K-Ras(G12C); decreases viability and… |
1 mg |
20118-1 |
More Info
|
K-Ras(G12C) Inhibitor 12 |
An allosteric inhibitor of oncogenic K-Ras(G12C); decreases viability and… |
10 mg |
20118-10 |
More Info
|
K-Ras(G12C) Inhibitor 12 |
An allosteric inhibitor of oncogenic K-Ras(G12C); decreases viability and… |
25 mg |
20118-25 |
More Info
|
K-Ras(G12C) Inhibitor 12 |
An allosteric inhibitor of oncogenic K-Ras(G12C); decreases viability and… |
5 mg |
20118-5 |
More Info
|